| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |